RPS6KB1 and colitis: Nicotine, a non-selective α7 nicotinic acetylcholine receptor (α7nAChR) agonist, ameliorates DSS-induced colitis in vivo and in vitro by activating the AMPK-mTOR-p70S6K signaling pathway.